
Kimberly-Clark Corporation
- What it sells
- Baby and Child Care is 41% and Family Care 25% of revenue (fiscal year to Dec 2025), from 41% and 23% two years earlier.
- Growing?
- Flat: revenue about the same as a year earlier (quarter ended Sep 2026); earnings per share up 68% over the last four quarters.
- Expensive?
- Cheaper than usual: 10.8× trailing earnings; its lowest in five years. Priced 68% below the peer median of 34.3x.
- Analysts?
- 44% of 16 say buy; average 12-month target $119, 11% above today's price.
- Risky?
- About average for a large company: its price swung 25% over the past year (the S&P 500's 14%), and it fell as much as 37% since Nov 2021.
Kimberly-Clark Corporation (KMB) is a global personal care and tissue company that manufactures and sells everyday consumer essentials—such as Huggies® diapers, Kleenex® facial tissue, Cottonelle® bath tissue, Scott® paper products, and Depend® adult care—primarily through retailers and distributors, earning revenue mainly from branded product sales.
More about Kimberly-Clark
Market Position
KMB competes as a large-scale, brand-led consumer staples manufacturer, differentiated by a portfolio of major global brands and proprietary materials/converting know-how across absorbent hygiene and tissue categories; its model relies on maintaining brand equity while managing input-cost volatility (notably pulp and petrochemical-based materials).
Key Segments
Kimberly-Clark reports three primary operating segments: Personal Care, Consumer Tissue, and K-C Professional.
How has the stock done?
Over the past month KMB rose 8.5%; the consumer staples ETF (XLP) rose 7.9% and the S&P 500 fell 2.7%.
Over the past six months KMB rose 10.1%; the consumer staples ETF (XLP) rose 7.8% and the S&P 500 rose 2.6%.
Over the past year KMB rose 2.9%; the consumer staples ETF (XLP) rose 17.8% and the S&P 500 rose 10.8%.
Over five years KMB fell 20.0%; the consumer staples ETF (XLP) rose 25.0% and the S&P 500 rose 62.0%.
From Sep 4, 2024 to Apr 7, 2026, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 0.1% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Nov 5, 2026 | ended Sep 2026 | $4.1B (0% vs a year earlier) | $1.70 vs $1.66 (beat) | −0.3% | −1.5% |
| Aug 4, 2026 | ended Jun 2026 | $4.2B (+1% vs a year earlier) | $2.12 vs $2.01 (beat) | +4.5% | +0.9% |
| Apr 28, 2026 | ended Mar 2026 | $4.2B (+3% vs a year earlier) | $1.97 vs $1.93 (beat) | −2.2% | −1.1% |
| Jan 27, 2026 | ended Dec 2025 | $4.1B (−1% vs a year earlier) | $1.86 vs $1.81 (beat) | −1.6% | −0.4% |
| Oct 30, 2025 | ended Sep 2025 | $4.2B (0% vs a year earlier) | — | +2.6% | −13.7% |
| Aug 1, 2025 | ended Jun 2025 | $4.2B (−2% vs a year earlier) | — | +6.8% | +9.3% |
| Apr 22, 2025 | ended Mar 2025 | $4.1B (−6% vs a year earlier) | — | −4.8% | −6.8% |
| Jan 28, 2025 | ended Dec 2024 | $4.1B (−1% vs a year earlier) | — | −1.3% | −1.6% |
| Oct 22, 2024 | ended Sep 2024 | $4.1B (−4% vs a year earlier) | — | −5.1% | −6.7% |
| Jul 23, 2024 | ended Jun 2024 | $4.2B (−2% vs a year earlier) | — | −2.5% | −5.4% |
| Apr 23, 2024 | ended Mar 2024 | $4.3B (−1% vs a year earlier) | — | +6.9% | +5.9% |
| Jan 24, 2024 | ended Dec 2023 | $5.0B (0% vs a year earlier) | — | −3.6% | −3.2% |
| Oct 24, 2023 | ended Sep 2023 | $5.1B (+2% vs a year earlier) | — | −2.5% | −1.8% |
| Jul 25, 2023 | ended Jun 2023 | $5.1B (+1% vs a year earlier) | — | −3.8% | −6.0% |
| Apr 25, 2023 | ended Mar 2023 | $5.2B (+2% vs a year earlier) | — | +0.8% | +2.4% |
| Jan 25, 2023 | ended Dec 2022 | $5.0B (0% vs a year earlier) | — | −3.2% | −3.4% |
| Oct 25, 2022 | ended Sep 2022 | $5.1B (+1% vs a year earlier) | — | +3.8% | +7.3% |
| Jul 26, 2022 | ended Jun 2022 | $5.1B (+7% vs a year earlier) | — | −1.0% | −0.3% |
| Apr 22, 2022 | ended Mar 2022 | $5.1B (+7% vs a year earlier) | — | +12.0% | +8.4% |
| Jan 26, 2022 | ended Dec 2021 | $5.0B (+3% vs a year earlier) | — | −1.5% | −2.9% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $4.1B in the quarter ended Sep 2026, about the same as a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $5.0B | 0% |
| Mar 2023 | $5.2B | +2% |
| Jun 2023 | $5.1B | +1% |
| Sep 2023 | $5.1B | +2% |
| Dec 2023 | $5.0B | 0% |
| Mar 2024 | $4.3B | −1% |
| Jun 2024 | $4.2B | −2% |
| Sep 2024 | $4.1B | −4% |
| Dec 2024 | $4.1B | −1% |
| Mar 2025 | $4.1B | −6% |
| Jun 2025 | $4.2B | −2% |
| Sep 2025 | $4.2B | 0% |
| Dec 2025 | $4.1B | −1% |
| Mar 2026 | $4.2B | +3% |
| Jun 2026 | $4.2B | +1% |
| Sep 2026 | $4.1B | 0% |
Revenue went from $17.0B in FY22 to $16.4B in FY25; net income from $1.9B to $2.0B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $17.0B | $1.9B |
| FY23 | $17.1B | $1.8B |
| FY24 | $16.8B | $2.5B |
| FY25 | $16.4B | $2.0B |
In the fiscal year to Dec 2025, Baby and Child Care was 41% and Family Care was 25% of revenue; Professional fell from 14% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Baby and Child Care | $7.1B | 41% |
| FY2023 | Family Care | $4.0B | 23% |
| FY2023 | Professional | $2.4B | 14% |
| FY2023 | Adult Care | $1.8B | 11% |
| FY2023 | Feminine Care | $1.8B | 10% |
| FY2023 | All Other | $87M | 1% |
| FY2024 | Baby and Child Care | $7.1B | 42% |
| FY2024 | Family Care | $3.9B | 23% |
| FY2024 | Professional | $2.2B | 13% |
| FY2024 | Adult Care | $1.9B | 11% |
| FY2024 | Feminine Care | $1.7B | 10% |
| FY2024 | All Other | $84M | 0.5% |
| FY2025 | Baby and Child Care | $6.8B | 41% |
| FY2025 | Family Care | $4.1B | 25% |
| FY2025 | Adult Care | $1.9B | 12% |
| FY2025 | Professional | $1.8B | 11% |
| FY2025 | Feminine Care | $1.7B | 10% |
| FY2025 | All Other | $124M | 1% |
A year earlier $1.34
Diluted, from SEC filings
The P/E of 10.8× over the 68% EPS growth of the last four quarters; near 1 or below is cheap for the growth
Quarters: Kimberly-Clark Corporation's SEC filings, named by the month they end. Fiscal years: Kimberly-Clark Corporation's annual reports to the SEC.
How it makes money
Of every $100 in revenue, $12.3 ends up as net income. Net margin was roughly flat over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 32.8% | 14.3% | 10.2% |
| Mar 2023 | 33.2% | 15.1% | 10.9% |
| Jun 2023 | 33.7% | 2.2% | 2.0% |
| Sep 2023 | 35.8% | 15.1% | 11.4% |
| Dec 2023 | 34.9% | 13.5% | 10.2% |
| Mar 2024 | 39.0% | 19.7% | 15.0% |
| Jun 2024 | 37.7% | 12.7% | 12.9% |
| Sep 2024 | 37.7% | 24.8% | 21.9% |
| Dec 2024 | 35.2% | 10.2% | 10.9% |
| Mar 2025 | 37.2% | 15.6% | 14.0% |
| Jun 2025 | 35.0% | 14.2% | 12.2% |
| Sep 2025 | 36.0% | 15.0% | 10.7% |
| Dec 2025 | 35.9% | 12.4% | 12.2% |
| Mar 2026 | 36.8% | 18.1% | 16.0% |
| Jun 2026 | 38.3% | 15.1% | 8.2% |
| Sep 2026 | 34.9% | 12.5% | 43.4% |
Circled: Sep 2026 (net 43.4%, operating 12.5%). Net margin is usually about 2 points below operating margin; in that quarter net income includes the results of a business sold or spun off (discontinued operations), which operating income leaves out.
+3.4 pts over 3 years
−1.5 pts over 3 years
+0.9 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Kimberly-Clark Corporation's annual reports to the SEC; quarters: SEC filings.
Customers and suppliers
In its latest annual report Kimberly-Clark sells to Walmart; it names no suppliers.
Customers
Kimberly-Clark's 10-K for the year to Dec 2025 gives one customer's share of its revenue: Walmart Inc. (16%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Dec 2023 | Walmart Inc. | 15% | 10-K filed Feb 12, 2026 |
| Year ended Dec 2024 | Walmart Inc. | 16% | 10-K filed Feb 12, 2026 |
| Year ended Dec 2025 | Walmart Inc. | 16% | 10-K filed Feb 12, 2026 |
From Kimberly-Clark Corporation's 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Partners
Changes since the previous annual report (10-K filed Feb 13, 2025)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Walmart | customer | “Our largest customer, Walmart Inc., represented approximately 16% in 2025 and 2024 and 15% in 2023 of our net sales from continuing operations.” |
| KCM | partner · Kimberly-Clark invested in it | “As of December 31, 2025, our ownership interest in Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries ("KCM") was 47.9%.” |
Only the companies Kimberly-Clark names in its 10-K filed Feb 12, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 10.8x, below the peer median of 34.3x, with earnings still growing.
Priced 68% below the peer median of 34.3x.
Show the data
| Company | P/E (trailing) |
|---|---|
| EL · The Estée Lauder Companies Inc. | 111× |
| CL · Colgate-Palmolive Company | 38.2× |
| CHD · Church & Dwight Co., Inc. | 34.3× |
| PG · The Procter & Gamble Company | 25.3× |
| KVUE · Kenvue Inc | 21.9× |
| KMB · Kimberly-Clark Corporation | 10.8× |
At 10.8× trailing earnings KMB is at its lowest in five years; the five-year median is 22.5×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 22.6× |
| Feb 8, 2022 | 24.9× |
| May 10, 2022 | 26.9× |
| Aug 10, 2022 | 25.7× |
| Nov 8, 2022 | 23.7× |
| Feb 9, 2023 | 22.4× |
| May 11, 2023 | 24.6× |
| Aug 11, 2023 | 26.4× |
| Nov 9, 2023 | 23.1× |
| Feb 12, 2024 | 23.0× |
| May 13, 2024 | 25.0× |
| Aug 13, 2024 | 20.5× |
| Nov 11, 2024 | 17.3× |
| Feb 13, 2025 | 17.9× |
| May 15, 2025 | 18.7× |
| Aug 15, 2025 | 18.3× |
| Nov 13, 2025 | 17.7× |
| Feb 17, 2026 | 17.7× |
| May 18, 2026 | 15.2× |
| Aug 18, 2026 | 18.3× |
| Nov 12, 2026 | 10.8× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $119, 11% above the current price; 44% of 16 analysts rate it a buy; earnings beat estimates in all of the last 4 quarters.
Buy or Strong Buy: 7 analysts (44%). Sell or Strong Sell: 1.
Over the past year the average of the analysts' latest price targets went from $123.70 to $113.25 (−8%), while KMB went from $104.45 to $107.19 (+3%). In the past three months targets were raised 6 times and cut 5 times. 1 upgrade and no downgrades over the year; the latest: Argus Research moved it to Buy from Hold on Nov 13, 2025.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Nov 9, 2026 | BNP Paribas | Target raised | Neutral | $112.00, was $110.00 |
| Nov 9, 2026 | Barclays | Target raised | Equal-Weight | $112.00, was $106.00 |
| Nov 6, 2026 | Piper Sandler | Target raised | Overweight | $137.00, was $118.00 |
| Nov 6, 2026 | Wells Fargo | Target raised | Equal-Weight | $110.00, was $100.00 |
| Oct 28, 2026 | UBS | Target raised | Neutral | $113.00, was $106.00 |
| Oct 23, 2026 | Canaccord Genuity | Began coverage | Hold | $105.00 |
| Oct 16, 2026 | BNP Paribas | Target raised | Neutral | $110.00, was $101.00 |
| Oct 13, 2026 | TD Cowen | Target cut | Hold | $97.00, was $104.00 |
| Oct 5, 2026 | Wells Fargo | Target cut | Equal-Weight | $100.00, was $105.00 |
| Sep 25, 2026 | B of A Securities | Target cut | Buy | $120.00, was $122.00 |
| Sep 11, 2026 | Piper Sandler | Target cut | Overweight | $118.00, was $121.00 |
| Sep 10, 2026 | Wells Fargo | Target cut | Equal-Weight | $105.00, was $110.00 |
| Aug 5, 2026 | UBS | Target raised | Neutral | $116.00, was $115.00 |
| Aug 5, 2026 | TD Cowen | Target raised | Hold | $104.00, was $96.00 |
| Jul 21, 2026 | Barclays | Target raised | Equal-Weight | $115.00, was $101.00 |
| Jul 16, 2026 | UBS | Target raised | Neutral | $115.00, was $106.00 |
| Jul 8, 2026 | Wells Fargo | Target raised | Equal-Weight | $110.00, was $100.00 |
| Jun 17, 2026 | Piper Sandler | Target raised | Overweight | $121.00, was $115.00 |
| Apr 29, 2026 | UBS | Target raised | Neutral | $106.00, was $105.00 |
| Apr 14, 2026 | Barclays | Target cut | Equal-Weight | $99.00, was $105.00 |
| Apr 10, 2026 | B of A Securities | Target cut | Buy | $120.00, was $130.00 |
| Apr 8, 2026 | Wells Fargo | Target cut | Equal-Weight | $100.00, was $110.00 |
| Apr 7, 2026 | UBS | Target cut | Neutral | $105.00, was $110.00 |
| Mar 30, 2026 | Deutsche Bank | Target cut | Hold | $109.00, was $110.00 |
| Mar 13, 2026 | Piper Sandler | Target cut | Overweight | $114.00, was $133.00 |
| Jan 28, 2026 | UBS | Target raised | Neutral | $110.00, was $107.00 |
| Jan 14, 2026 | Citigroup | Target cut | Sell | $90.00, was $95.00 |
| Jan 14, 2026 | UBS | Target cut | Neutral | $107.00, was $132.00 |
| Jan 8, 2026 | TD Cowen | Target cut | Hold | $105.00, was $112.00 |
| Jan 5, 2026 | Wells Fargo | Target cut | Equal-Weight | $105.00, was $110.00 |
| Dec 17, 2025 | Citigroup | Target cut | Sell | $95.00, was $100.00 |
| Dec 1, 2025 | BNP Paribas Exane | Target cut | Neutral | $110.00, was $127.00 |
| Nov 13, 2025 | Argus Research | Upgrade | Buy, was Hold | $120.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $1.81 | $1.86 | +2.8% |
| Mar ’26 | $1.93 | $1.97 | +2.1% |
| Jun ’26 | $2.01 | $2.12 | +5.5% |
| Sep ’26 | $1.66 | $1.70 | +2.4% |
The day after each of these reports the stock moved −1.6% (Dec 2025, beat); −2.2% (Mar 2026, beat); +4.5% (Jun 2026, beat); −0.3% (Sep 2026, beat).
For the quarter ending Dec 2026 (Kimberly-Clark reports on Feb 2, 2027), analysts expect adjusted earnings of $1.53 a share, 18% less than the $1.86 of a year earlier, and revenue of $6.7B, up 65% on a year earlier. For the fiscal year ending Dec 2026, they expect revenue of $19.3B, up 18% on the year before.
Adjusted. Dec 2025: $1.86; range $1.25 to $1.62; 8 analysts
Dec 2025: $4.1B; range $6.6B to $6.8B; 4 analysts
The year to Dec 2025: $16.4B; range $19.1B to $20.1B; 6 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Feb 2, 2027 | EPS (adjusted) | $1.53 | $1.25 to $1.62 | 8 | $1.86 (Dec 2025) | −18% |
| Quarter ending Dec 2026, results Feb 2, 2027 | Revenue | $6.7B | $6.6B to $6.8B | 4 | $4.1B (Dec 2025) | +65% |
| Quarter ending Mar 2027 | EPS (adjusted) | $1.77 | $1.65 to $1.85 | 7 | $1.97 (Mar 2026) | −10% |
| Quarter ending Mar 2027 | Revenue | $8.2B | $8.2B to $8.3B | 4 | $4.2B (Mar 2026) | +97% |
| Year ending Dec 2026 | Revenue | $19.3B | $19.1B to $20.1B | 6 | $16.4B (year to Dec 2025) | +18% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $1.9B in free cash flow over the year, of which $1.7B went back to shareholders (dividends plus buybacks), leaving $260M in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $3.4B |
| Capex | −$1.4B |
| Free cash flow | $1.9B |
| Dividends | −$1.7B |
| Buybacks | — |
| Cash retained | $260M |
For every $100 of market cap, the company generates about $2.9 in free cash flow a year.
For every $100 of market cap, you receive about $4.8 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $2.6 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $998M | $399M | $130M |
| Mar 2024 | $244M | $398M | $54M |
| Jun 2024 | $863M | $411M | $102M |
| Sep 2024 | $798M | $411M | $596M |
| Dec 2024 | $608M | $408M | $248M |
| Mar 2025 | $123M | $405M | $61M |
| Jun 2025 | $573M | $419M | $59M |
| Sep 2025 | $368M | $418M | $20M |
| Dec 2025 | $575M | $418M | $1.0M |
| Mar 2026 | $321M | $418M | $0 |
| Jun 2026 | $556M | $425M | $0 |
| Sep 2026 | $492M | $425M | $0 |
Kimberly-Clark had 334M diluted shares in the quarter ended Sep 2026, 0.2% more than a year earlier, and 0.4% fewer each year on average since Jun 2020. It spent $1.0M on buybacks over the last four quarters. Over the last four quarters its earnings per share rose 67.7% and its net income rose 67.7%: more shares took about 0 points off.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Jun 2020 | 342M |
| Sep 2020 | 342M |
| Mar 2021 | 339M |
| Jun 2021 | 338M |
| Sep 2021 | 338M |
| Mar 2022 | 338M |
| Jun 2022 | 338M |
| Sep 2022 | 338M |
| Mar 2023 | 339M |
| Jun 2023 | 339M |
| Sep 2023 | 339M |
| Mar 2024 | 338M |
| Jun 2024 | 338M |
| Sep 2024 | 337M |
| Mar 2025 | 333M |
| Jun 2025 | 333M |
| Sep 2025 | 333M |
| Mar 2026 | 333M |
| Jun 2026 | 333M |
| Sep 2026 | 334M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 0.7, short-term debt coverage is tight; shareholder equity is only 9% of assets, so debt-to-equity (4.8) says little; net debt is 1.9 years of operating cash flow, which is manageable.
Assets that can be turned into cash soon are 0.7x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
Shareholder funds are only 9% of assets, so $4.8 of debt per $1 of them says little about whether the debt can be carried. The years of operating cash flow it would take to repay it say more.
Cash and short-term investments of $774M against debt of $7.2B. Lease obligations of $128M are not counted: they are rent owed, not money borrowed. It also holds $330M of long-term investments, which can be stakes in other companies rather than cash.
Net debt of $6.4B is 1.9 years of the $3.4B its operations brought in over the last four quarters. Under 1 year is light; over 3 is heavy.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 2 members of Congress and 6 funds whose copy leaves KMB out (not traded on the exchange): Mirae Asset Global Investments, Bridgewater Associates, Norges Bank, Dan Meuser, Swiss National Bank, Canada Pension Plan Investment Board and 2 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 10 held KMB at the end of their latest quarter (for most, Q2 2026). Over that quarter 8 added shares, 2 cut and 1 sold all. The largest of them is Norges Bank, 5.77M shares worth $634M at Jun 30, 2026, 11.8% more than at Dec 31, 2025.
Over their latest quarter
1 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 5.77M | $634M | +607,755 | +12% | Aug 12, 2026 |
| Renaissance Technologies | Q3 2026 | 2.41M | $235M | +911,300 | +61% | Nov 12, 2026 |
| Swiss National Bank | Q3 2026 | 907,800 | $88.4M | −28,500 | −3.0% | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 692,032 | $67.5M | +426 | +0.1% | Nov 12, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 425,116 | $41.4M | +51,196 | +14% | Nov 3, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 243,986 | $26.8M | −79,478 | −25% | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 150,116 | $16.5M | +130,798 | +677% | Aug 14, 2026 |
| Fisher Asset Management | Q3 2026 | 69,621 | $6.8M | +29,743 | +75% | Nov 6, 2026 |
| Korea Investment | Q2 2026 | 54,210 | $6.0M | +19,400 | +56% | Aug 12, 2026 |
| Nomura Holdings | Q2 2026 | 24,722 | $2.7M | +16,669 | +207% | Aug 14, 2026 |
| Maverick Capital | Q2 2026 | 0 | — | −19,028 | Sold all | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of KMB at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.